Blog
EU Parliament Backs New Genome Techniques in Plant Breeding: What You Need to Know
🌱 MEPs support rules distinguishing NGT breeds, 307 votes to 263, with 41 abstentions. 🚫 Ban on patents, mandatory labeling, and organic farming. ✅ NGT1 exempt from GMO requirements. ⚖️ Commission and Council to decide, opposition from Poland may delay approval.
Revolutionizing Biopharma: The Future of Model Predictive Control
🌟 Model Predictive Control (MPC) uses mathematical models to anticipate future behavior, allowing for strategic adjustments in real-time. 💪 ⚙️ Technological advancements are improving the implementation of MPC, making it more accessible and feasible. ⏳ 💡 Integrating MPC with Process Analytical Technology (PAT) ensures precise and consistent product quality. 🚀
Cutting Costs in Biomanufacturing: Expert Engineering Insights
🔍 Engineer offers cost-cutting advice to biomanufacturers 🔬💰⚙️💊- Learn how engineering insights can help reduce production costs in the pharmaceutical industry. 🧪📉
Revolutionary Partnership: Purolite and Repligen Transform mAbs Purification Process
💡 Purolite and Repligen collaborate on advanced chromatography resins for efficient purification of mAbs in biopharmaceutical production.🔬💉
Revolutionary Hybrid Approach Speeds Up Process Development
🔬💡✅🧪⏭️ Hybrid High-Throughput Process Development explores a novel approach using digital twins, predictive models, and high-throughput screening.
Revolutionizing Bioprocessing with Advanced Image Analysis
🔍 Expanding Applications of Image Analysis explores the potential of imaging in bioprocessing and biotechnology, including machine learning and in situ microscopy. 📸
Game-Changing Merger Propels Biovian and 3P Globally
🔎 CDMOs Biovian and 3P merge to expand globally, covering the entire biotech development process. 🌍💼🤝📈
Evotec’s Breakthrough: Expanding HIV Antibody Deal
📰 Evotec expands anti-HIV antibody deal with ABL to develop and manufacture neutralizing antibodies against HIV. Just-Evotec Biologics to develop third antibody and provide manufacturing services for Phase I clinical study. Partnership aims to deliver new HIV therapies. 💉🌍
AstraZeneca’s $300M Expansion Ignites Cell and Gene Therapy Revolution
AstraZeneca invests $300m in new research facility in Cambridge, UK to advance cell and gene therapies. 💉🔬💼🔍👥
Jazz Pharma Pays $10 Million for Cancer Treatment Breakthrough
🎯 Jazz Pharmaceuticals secures KRAS blockers from Redx Pharma 💰 $10M upfront, up to $870M milestones 💊 Enhancing cancer treatment options.
